Provided by Tiger Trade Technology Pte. Ltd.

IQVIA

261.77
+4.471.74%
Post-market: 261.770.00000.00%19:30 EDT
Volume:1.43M
Turnover:372.44M
Market Cap:43.09B
PE:32.43
High:262.89
Open:258.82
Low:256.97
Close:257.30
52wk High:271.80
52wk Low:154.50
Shares:164.60M
Float Shares:151.00M
Volume Ratio:1.02
T/O Rate:0.95%
Dividend:- -
Dividend Rate:- -
EPS(TTM):8.07
EPS(LYR):7.84
ROE:22.82%
ROA:5.06%
PB:6.98
PE(LYR):33.39

Loading ...

Gartner Inc. Stock Falls 4.2%, Underperforms Peers

Dow Jones
·
Aug 13

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Aug 12

Gartner Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 11

IQVIA Holdings Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 11

IQVIA Holdings Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 08

IQVIA Holdings Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 06

Top IQVIA Execs Quietly Cash In on Major Stock Move

TIPRANKS
·
Aug 05

IQVIA President MedTech and Consumer Health Bhavik Patel Sells 1,855 Shares for $436,927.85

Reuters
·
Aug 05

IQVIA Partners with Medera to Advance Cardiac Gene Therapy Development

Reuters
·
Aug 05

IQVIA Holdings Inc. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Aug 05

Gartner Inc. Stock Climbs 22.6%, Outperforms Peers

Dow Jones
·
Aug 05

IQVIA and Medera to Advance Cardiac Gene Therapy and Human-Based Drug Discovery

THOMSON REUTERS
·
Aug 05

THRIVE Trial Puts IQVIA in Focus as Renal Denervation Race Heats Up

TIPRANKS
·
Aug 04

Top IQVIA Insiders Quietly Unload Millions in Company Stock

TIPRANKS
·
Aug 01

IQVIA CEO Ari Bousbib Disposes of Common Shares Worth $26.23 Million

Reuters
·
Aug 01

IQVIA Holdings Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Aug 01

Gartner Inc. Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Jul 31

IQVIA Holdings Inc : Mizuho Raises Target Price to $275 from $230

THOMSON REUTERS
·
Jul 30

Movement Alert|IQVIA Rises 5.03% Overnight, RBC Raises Price Target to $247 Citing Favorable Margin Expansion Outlook

Market Focus
·
Jul 30

Clinical Research Firm ICON's Q2 Revenue Rises 1.2%, Beats Analyst Estimates

Reuters
·
Jul 30